Owen A - Search Results

1

Use of a physiologically based pharmacokinetic model to simulate drug-drug interactions between antineoplastic and antiretroviral drugs.

Moltó J, Rajoli R, Back D, Valle M, Miranda C, Owen A, Clotet B, Siccardi M. Moltó J, et al. Among authors: owen a. J Antimicrob Chemother. 2017 Mar 1;72(3):805-811. doi: 10.1093/jac/dkw485. J Antimicrob Chemother. 2017. PMID: 27999009

2

The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro.

Chandler B, Almond L, Ford J, Owen A, Hoggard P, Khoo S, Back D. Chandler B, et al. Among authors: owen a. J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):551-6. doi: 10.1097/00126334-200308150-00001. J Acquir Immune Defic Syndr. 2003. PMID: 12902797

3

The implications of P-glycoprotein in HIV: friend or foe?

Owen A, Chandler B, Back DJ. Owen A, et al. Fundam Clin Pharmacol. 2005 Jun;19(3):283-96. doi: 10.1111/j.1472-8206.2005.00324.x. Fundam Clin Pharmacol. 2005. PMID: 15910652 Review.

4

In vitro synergy and enhanced murine brain penetration of saquinavir coadministered with mefloquine.

Owen A, Janneh O, Hartkoorn RC, Chandler B, Bray PG, Martin P, Ward SA, Hart CA, Khoo SH, Back DJ. Owen A, et al. J Pharmacol Exp Ther. 2005 Sep;314(3):1202-9. doi: 10.1124/jpet.105.086272. Epub 2005 May 27. J Pharmacol Exp Ther. 2005. PMID: 15923343

5

Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP.

Janneh O, Owen A, Chandler B, Hartkoorn RC, Hart CA, Bray PG, Ward SA, Back DJ, Khoo SH. Janneh O, et al. Among authors: owen a. AIDS. 2005 Dec 2;19(18):2097-102. doi: 10.1097/01.aids.0000194793.36175.40. AIDS. 2005. PMID: 16284458

6

Population pharmacokinetics of efavirenz in an unselected cohort of HIV-1-infected individuals.

Back DJ, Owen A, Khoo SH. Back DJ, et al. Among authors: owen a. Clin Pharmacokinet. 2006;45(2):213-4; author reply 214-5. doi: 10.2165/00003088-200645020-00006. Clin Pharmacokinet. 2006. PMID: 16485918 No abstract available.

7

Pharmacogenetics of HIV therapy.

Owen A, Pirmohamed M, Khoo SH, Back DJ. Owen A, et al. Pharmacogenet Genomics. 2006 Oct;16(10):693-703. doi: 10.1097/01.fpc.0000236338.41799.57. Pharmacogenet Genomics. 2006. PMID: 17001288

8

Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.

Hartkoorn RC, Chandler B, Owen A, Ward SA, Bertel Squire S, Back DJ, Khoo SH. Hartkoorn RC, et al. Among authors: owen a. Tuberculosis (Edinb). 2007 May;87(3):248-55. doi: 10.1016/j.tube.2006.12.001. Epub 2007 Jan 26. Tuberculosis (Edinb). 2007. PMID: 17258938

9

Factors impacting the expression of membrane-bound proteins in lymphocytes from HIV-positive subjects.

Chandler B, Detsika M, Khoo SH, Williams J, Back DJ, Owen A. Chandler B, et al. Among authors: owen a. J Antimicrob Chemother. 2007 Sep;60(3):685-9. doi: 10.1093/jac/dkm230. Epub 2007 Jul 2. J Antimicrob Chemother. 2007. PMID: 17606483

10

Detection and quantification of minority HIV isolates harbouring the D30N mutation by real-time PCR amplification.

Detsika MG, Chandler B, Khoo SH, Winstanley C, Cane P, Back DJ, Owen A. Detsika MG, et al. Among authors: owen a. J Antimicrob Chemother. 2007 Oct;60(4):881-4. doi: 10.1093/jac/dkm281. Epub 2007 Jul 23. J Antimicrob Chemother. 2007. PMID: 17650515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,551 results

Search Page

Filters